SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-20-044699
Filing Date
2020-04-08
Accepted
2020-04-08 17:04:34
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-1 tm2015238d1_s1.htm S-1 242597
2 EXHIBIT 5.1 tm2015238d1_ex5-1.htm EX-5.1 10365
3 EXHIBIT 23.1 tm2015238d1_ex23-1.htm EX-23.1 2979
4 GRAPHIC image_003.jpg GRAPHIC 10434
5 GRAPHIC image_001.jpg GRAPHIC 6379
6 GRAPHIC image_002.jpg GRAPHIC 6371
  Complete submission text file 0001104659-20-044699.txt   289328
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-1 | Act: 33 | File No.: 333-237607 | Film No.: 20782503
SIC: 2836 Biological Products, (No Diagnostic Substances)